middle.news

Lumos Diagnostics Lands US$1.3M FebriDx® Order After FDA Boost

11:02am on Wednesday 1st of April, 2026 AEDT Healthcare
Read Story

Lumos Diagnostics Lands US$1.3M FebriDx® Order After FDA Boost

11:02am on Wednesday 1st of April, 2026 AEDT
Key Points
  • Largest FebriDx® purchase order valued at US$1.3 million
  • Order placed by US exclusive distributor PHASE Scientific
  • Follows FDA 510(k) clearance with CLIA waiver granted in March 2026
  • Market opportunity expanded to over US$1 billion in the US
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about LUMOS DIAGNOSTICS HOLDINGS (ASX:LDX)
OPEN ARTICLE